Conn Syndrome


Article Author:
Malvinder Parmar


Article Editor:
Shikha Singh


Editors In Chief:
Jon Parham
Abigail Frank
Jon Sivoravong


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Frank Smeeks
Kristina Soman-Faulkner
Trevor Nezwek
Radia Jamil
Patrick Le
Sobhan Daneshfar
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Pritesh Sheth
Hassam Zulfiqar
Navid Mahabadi
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
6/18/2019 3:41:26 AM

Introduction

Conn syndrome was named after J. W. Conn who first decribed it in 1955, in a patient who had hypertension with an aldosterone-producing adenoma. The ademona is characterized by increased aldosterone secretion from the adrenal glands, suppressed plasma renin, hypertension, and hypokalemia. Later, many other cases of adrenal hyperplasia with inappropriately elevated aldosterone secretion were described, and now the term primary hyperaldosteronism is used to describe Conn syndrome irrespective of whether the patient has an adenoma or not.

Etiology

The syndrome may be secondary to adrenal hyperplasia, adrenal adenoma, aldosterone-secreting adrenal carcinoma (1%), or familial hyperaldosteronism (FH).

Various specific genetic alterations (see below) have been identified for rare familial forms of the disease. In a majority of these genetic alterations, the end point is Ca influx and membrane depolarization resulting in aldosterone hypersecretion.

Familial hyperaldosteronism (FH) type 1: Unequal crossing over between highly homologous CYP11B2 and CYP11B1 genes that code of aldosterone synthase and steroid 11 B-hydroxylase, resulting in a chimeric gene that is under adrenocorticotrophin (ACTH) rather than RAS control.

Familial hyperaldosteronism (FH) type 2: Autosomal dominant, heterogeneous, no response to dexamethasone suppression, possibly link with chromosome 7p22.

Familial hyperaldosteronism (FH) type 3: Mutations in the gene encoding the inwardly rectifying potassium channel Kir3.4 (KCNJ5 gene). Specific mutations in KCNJ5 gene, like those altering the G151E amino acid, are associated with a milder form of aldosteronism, compared to those with a G151R mutation that have a more severe form.

Mutations in three other genes encoding for membrane proteins (Na/K-ATPase (ATP1A), ca ATPase (ATP2B3) and Ca1.3 (CACNAID) are associated with Ca influx and/or activated calcium signaling pathways leading to increased production of aldosterone by CYP11B2 gene.

Recently, a single-nucleotide polymorphism (c.-2G>C) of the NR3C2 gene that codes for mineralocorticoid receptor (MR) has been shown to be associated with increased activation of RAS and increased blood pressure in the general population.

Epidemiology

Primary hyperaldosteronism is the most common cause of secondary hypertension and occurs in about 6% to 20% of adult hypertensive patients, higher in patients with resistant hypertension. The prevalence of 10% was noted when consecutive patients with hypertension were evaluated. However, the prevalence increased to 30% when aldosterone to renin ratio (ARR) was used as a screening method in general practice.

Aldosterone-producing adenoma is present in 50% to 60%, and the remaining is idiopathic or bilateral adrenal hyperplasia. It is about two times more common in women than men.

Pathophysiology

Primary hyperaldosteronism is caused by aldosterone-producing adenomas, bilateral idiopathic adrenal hyperplasia, aldosterone-producing adrenal carcinoma, and familial aldosteronism. The increased amount of aldosterone potentiates renal sodium reabsorption and water retention, and potassium excretion. The increased sodium reabsorption by the kidneys results in plasma volume expansion which is the primary initiating mechanism for hypertension. This may induce tissue inflammation and heightened sympathetic drive, with subsequent development of fibrosis in vital organs, such as heart, kidneys, and vasculature. As a result, this may lead to the development of chronic kidney disease, atrial fibrillation, stroke, ischemic heart disease and congestive heart failure.

Histopathology

Histopathology is often heterogeneous ranging from micronodular or macronodular hyperplasia with adenoma formation, with atrophy or diffuse or nodular hyperplasia of the adjacent adrenal cortex.

History and Physical

Often, the patients are asymptomatic but may present with symptoms of fatigue, muscle weakness, cramping (secondary to potassium wasting), headaches, and palpitations. They can also have polydipsia and polyuria from hypokalemia-induced nephrogenic diabetes insipidus.

Evaluation

Hypokalemia in a hypertensive patient is the most common clue for primary hyperaldosteronism. However, normal serum potassium may be present in up to 38% of patients, especially in patients with adrenal hyperplasia or familial aldosteronism.

  • Urinary potassium excretion is elevated (more than 30 mmol/day).
  • Diagnosis depends on the demonstration of expanded extracellular fluid (ECF) volume (suppressed plasma renin) and non-suppressible aldosterone secretion.
  • ARR (aldosterone: renin ratio): The lack of uniform assay method and diagnostic protocols in assessing the results creates a high variability in cut-off values among various investigators. A ratio of 40 or more (20 ng/dL/h to 40 ng/dL/h) or more than 135 (68 pmol/mU to 135 pmol/mU) has a sensitivity of 73% to 93% and a specificity of 71% to 84%, indicating the need for further confirmatory studies with salt-loading (failure to lower plasma aldosterone level less than 10 ng/dL), fludrocortisone suppression test, or captopril suppression test. The Endocrine Society's clinical practice guidelines do not specify which of these confirmatory tests should be regarded as the gold standard to confirm or exclude the diagnosis; therefore, different tests are performed by different centers.
  • Once autonomous aldosterone production is established, next step is to evaluate for possible adenoma. CT scan may show an adenoma that accounts for 70% cases, but as milder forms are being recognized now, idiopathic hyperaldosteronism is the most common cause. However, CT may provide incorrect diagnosis because of the common occurrence of non-functional adrenal adenomas (incidentalomas) that may be present in 4% of the general population.
  • The studies to confirm unilateral nature of adrenal hypersecretion (lateralization) either by adrenal venous sampling (invasive, difficult and possible complications) or byiodocholesterol adrenal scan have limitations. 
  • Plasma 18-hydroxycorticosterone is elevated in adenoma and normal in adrenal hyperplasia.
  • A plasma aldosterone response to a two-hour upright position shows normal increase in adrenal hyperplasia but a paradoxical decrease in adrenal adenoma.

When to screen?

  • Patients with stage 2 or stage 3 hypertension
  • Resistant hypertension
  • Hypertension with spontaneous or diuretic-induced hypokalemia
  • Hypertension with adrenal incidentaloma
  • Hypertension with a family history of early onset hypertension or cerebrovascular disease
  • Patients with first-degree relatives diagnosed with Primary aldosteronism
  • Any patient with suspected secondary hypertension

Treatment / Management

Unilateral adrenalectomy in patients with a unilateral adenoma (Conn syndrome) cures hypertension in 30 % to 60% of cases, but the mean cure rate is only 19% after unilateral or bilateral adrenalectomy in patients with idiopathic hyperaldosteronism whose treatment mainly is medical. This treatment includes aldosterone antagonists such as spironolactone or eplerenone or other potassium-sparing diuretics like amiloride.

Pearls and Other Issues

Normal serum potassium level does not exclude primary hyperaldosteronism. Several studies have shown that 7% to 38% of patients with primary hyperaldosteronism have normal baseline
serum potassium levels, especially patients with hypertension who are often advised to restrict their salt intake. The hypokalemia becomes evident with the liberalization of dietary sodium intake.

The ARR may be falsely elevated in patients with chronic kidney disease, patients on potassium supplements or beta-blockers. Diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers may cause false negative results. If the clinical suspicion is high, ARR should be repeated after holding these agents for two weeks.

 


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Conn Syndrome - Questions

Take a quiz of the questions on this article.

Take Quiz
Which is not associated with Conn syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which medication is used to treat Conn syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which medication is the first line treatment for Conn syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 27-year-old male has had hard to control hypertension for 2 years. He is taking clonidine, hydrochlorothiazide, verapamil, and lisinopril. His blood pressure is 170/105 mmHg, pulse 90 beats/min, and respirations 16. The cardiopulmonary exam is normal. Pedal pulses are intact and there is no edema or misdistribution of fat. Laboratories show potassium of 2.7 mEq/L, BUN 20 mg/dL, creatinine 1.2 mg/dL, bicarbonate 33 mg/dL, and fasting glucose 98 mg/dL. What is the most likely diagnosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Select the best test for Conn syndrome.



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What are expected manifestations associated with Conn syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 49 year old female complains of leg cramps, muscle weakness, and headaches. She has no significant medical history. Exam shows mild elevation of blood pressure but is otherwise normal. Laboratories show mild hypernatremia, hypokalemia, normal glucose, BUN, and creatinine. CT show right adrenal gland cortical tumor. Select the most probable hormone abnormalities.



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 41-year-old male complains of generalized headaches, weakness, and fatigue for a few weeks. The blood pressure is 130/100 mmHg, heart rate 80, and respirations 16. Laboratories show sodium 140 meq/L, potassium 3.0 mg/L, chloride 108 meq/L, BUN 20 mg/dL, creatinine 1.1 mg/dL, and renin was low. What is the most likely etiology?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 46-year-old man has mild renal failure and hypertension which is proving difficult to manage. CT scan shows both a small adrenal tumor and bilateral hyperplasia. Which of the following is the best test to make a definitive diagnosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Conn Syndrome - References

References

Deinum J,Groenewoud H,Wilt GJV,Rossi G,Lenzini L, Adrenal venous sampling: cosyntropin stimulation or not? European journal of endocrinology. 2019 Jun 1;     [PubMed]
Cobb A,Aeddula NR, Primary Hyperaldosteronism 2019 Jan;     [PubMed]
Corssmit EPM,Dekkers OM, Screening in adrenal tumors. Current opinion in oncology. 2019 May;     [PubMed]
Stowasser M,Wolley M,Wu A,Gordon RD,Schewe J,Stölting G,Scholl UI, Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels. Current hypertension reports. 2019 Apr 4;     [PubMed]
Chikladze NM,Favorova OO,Chazova IE, Family hyperaldosteronism type I: a clinical case and review of literature. Terapevticheskii arkhiv. 2018 Sep 20;     [PubMed]
Morera J,Reznik Y, MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronism. European journal of endocrinology. 2019 Feb 1;     [PubMed]
Infante M,Armani A,Marzolla V,Fabbri A,Caprio M, Adipocyte Mineralocorticoid Receptor. Vitamins and hormones. 2019;     [PubMed]
Chan PL,Tan FHS, Renin dependent hypertension caused by accessory renal arteries. Clinical hypertension. 2018;     [PubMed]
Schilbach K,Junnila RK,Bidlingmaier M, Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism. Experimental and clinical endocrinology     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Family Medicine. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Family Medicine, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Family Medicine, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Family Medicine. When it is time for the Family Medicine board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Family Medicine.